|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.4108 - 0.4108|
|52 Week Range||0.4108 - 0.4108|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Multi-Year Agreement to Utilize Player's Name, Endorsement and Likeness in Connection With the Advertisement, Promotion and Sale of the Jupiter Wellness Brands CaniSun, CaniSkin and CaniDermRxJUPITER, FL / ACCESSWIRE / November 19, 2020 / Jupiter Wellness, Inc.
* Marks Jupiter's 3rd Clinical Indication Including Eczema and Burns * Study Data to Be Used in Planned IND Filing With U.
Study data to be used in planned IND filing with U.